98 related articles for article (PubMed ID: 17229590)
1. Changing views on Langerhans cell functions in leishmaniasis.
Moreno J
Trends Parasitol; 2007 Mar; 23(3):86-8. PubMed ID: 17229590
[TBL] [Abstract][Full Text] [Related]
2. [Role of Langerhans cells in the immunity of leishmaniasis].
Zuluaga M; Robledo SM
Biomedica; 2004 Sep; 24(3):302-17. PubMed ID: 15551883
[TBL] [Abstract][Full Text] [Related]
3. Epidermal inoculation of Leishmania-antigen by gold bombardment results in a chronic form of leishmaniasis.
Weiss R; Scheiblhofer S; Thalhamer J; Bickert T; Richardt U; Fleischer B; Ritter U
Vaccine; 2007 Jan; 25(1):25-33. PubMed ID: 17064826
[TBL] [Abstract][Full Text] [Related]
4. Comment on "TLR9-dependent activation of dendritic cells by DNA from Leishmania major favors Th1 cell development and the resolution of lesions".
Bogdan C; Schleicher U
J Immunol; 2009 Dec; 183(11):6859; author reply 6859. PubMed ID: 19923471
[No Abstract] [Full Text] [Related]
5. Reviewing the role of the dendritic Langerhans cells in the immunopathogenesis of American cutaneous leishmaniasis.
Silveira FT; Lainson R; Gomes CM; Laurenti MD; Corbett CE
Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1075-80. PubMed ID: 18602127
[TBL] [Abstract][Full Text] [Related]
6. Wild-type Leishmania donovani promastigotes block maturation, increase integrin expression and inhibit detachment of human monocyte-derived dendritic cells--the influence of phosphoglycans.
Tejle K; Lindroth M; Magnusson KE; Rasmusson B
FEMS Microbiol Lett; 2008 Feb; 279(1):92-102. PubMed ID: 18177309
[TBL] [Abstract][Full Text] [Related]
7. Immunization strategies against visceral leishmaniosis with the nucleosomal histones of Leishmania infantum encoded in DNA vaccine or pulsed in dendritic cells.
Carrión J; Folgueira C; Alonso C
Vaccine; 2008 May; 26(20):2537-44. PubMed ID: 18400342
[TBL] [Abstract][Full Text] [Related]
8. Differential migration of epidermal and dermal dendritic cells during skin infection.
Eidsmo L; Allan R; Caminschi I; van Rooijen N; Heath WR; Carbone FR
J Immunol; 2009 Mar; 182(5):3165-72. PubMed ID: 19234214
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the immunomodulatory effects of L. donovani and L. major excreted-secreted antigens, particulate and soluble extracts and viable parasites on human dendritic cells.
Revest M; Donaghy L; Cabillic F; Guiguen C; Gangneux JP
Vaccine; 2008 Nov; 26(48):6119-23. PubMed ID: 18804505
[TBL] [Abstract][Full Text] [Related]
10. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
11. Insights into Langerhans cell function from Langerhans cell ablation models.
Kaplan DH; Kissenpfennig A; Clausen BE
Eur J Immunol; 2008 Sep; 38(9):2369-76. PubMed ID: 18792030
[TBL] [Abstract][Full Text] [Related]
12. [Dendritic cells and protozoan infection].
Liu MY; Xu SM; Song GH
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2001; 19(6):367-70. PubMed ID: 12572076
[No Abstract] [Full Text] [Related]
13. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells.
Merad M; Ginhoux F; Collin M
Nat Rev Immunol; 2008 Dec; 8(12):935-47. PubMed ID: 19029989
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous leishmaniasis: progress towards a vaccine.
Launois P; Tacchini-Cottier F; Kieny MP
Expert Rev Vaccines; 2008 Oct; 7(8):1277-87. PubMed ID: 18844599
[TBL] [Abstract][Full Text] [Related]
15. In vivo induction of immune responses to pathogens by conventional dendritic cells.
López-Bravo M; Ardavín C
Immunity; 2008 Sep; 29(3):343-51. PubMed ID: 18799142
[TBL] [Abstract][Full Text] [Related]
16. Distinct roles for DC-SIGN+-dendritic cells and Langerhans cells in HIV-1 transmission.
de Witte L; Nabatov A; Geijtenbeek TB
Trends Mol Med; 2008 Jan; 14(1):12-9. PubMed ID: 18055263
[TBL] [Abstract][Full Text] [Related]
17. Successful vaccination against Leishmania chagasi infection in BALB/c mice with freeze-thawed Leishmania antigen and Corynebacterium parvum.
Vilela Mde C; Gomes DC; Marques-da-Silva Ede A; Serafim TD; Afonso LC; Rezende SA
Acta Trop; 2007; 104(2-3):133-9. PubMed ID: 17919443
[TBL] [Abstract][Full Text] [Related]
18. DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice.
Ahmed SB; Touihri L; Chtourou Y; Dellagi K; Bahloul C
Vaccine; 2009 Jan; 27(1):99-106. PubMed ID: 18951941
[TBL] [Abstract][Full Text] [Related]
19. Structural studies of langerin and Birbeck granule: a macromolecular organization model.
Thépaut M; Valladeau J; Nurisso A; Kahn R; Arnou B; Vivès C; Saeland S; Ebel C; Monnier C; Dezutter-Dambuyant C; Imberty A; Fieschi F
Biochemistry; 2009 Mar; 48(12):2684-98. PubMed ID: 19175323
[TBL] [Abstract][Full Text] [Related]
20. A role for transforming growth factor-beta1 in maintaining the differentiated state of Langerhans cells in human epidermis.
Pieri L; Domenici L; Romagnoli P
Ital J Anat Embryol; 2006; 111(3):133-49. PubMed ID: 17312920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
